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The first half of the surfactant protein B (SP-B) gene 
intron 4 is a CA-repeat-rich region that contains 11 
motifs. To study the role of this region on SP-B 
mRNA splicing, minigenes were generated by system-
atic removal of motifs from either the 5’ or 3’ end. 
These were transfected in CHO cells to study their 
splicing efficiency. The latter was determined as the 
ratio of completely to incompletely spliced SP-B 
RNA. Our results indicate that SP-B intron 4 motifs 
differentially affect splicing. Motifs 8 and 9 signifi-
cantly enhanced and reduced splicing of intron 4, re-
spectively.  RNA mobility shift assays performed with 
a Motif 8 sequence that contains a CAUC cis-element 
and cell extracts resulted in a RNA:protein shift that 
was lost upon mutation of the element. Furthermore, in 
silico analysis of mRNA secondary structure stability 
for minigenes with and without motif 8 indicated a 
correlation between mRNA stability and splicing ratio.  
We conclude that differential loss of specific intron 4 
motifs results in one or more of the following: a) al-
tered splicing, b) differences in RNA stability and c)
changes in secondary structure. These, in turn, may 
affect SP-B content in lung health or disease. 
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Introduction 
 
Messenger RNA splicing is essential for generating 
mature mRNAs and forming highly complex pro-
teomes from a relatively small number of human genes 
(Hui et al. 2005, Hung et al. 2008, Lin et al. 2005).  
An accurate mRNA splicing process requires three 
essential core sequence elements: the 5’ splice site 
(5’ss), 3’ splice site (3’ss), and the branch point (BP) 
sequence.  These sequences are recognized by compo-
nents of the spliceosome during the processes of intron 
removal and exon joining (Pastor et al. 2009, Ward & 
Cooper 2010). However, these three core sequences 
are necessary but not sufficient for defining intron–
exon junctions. There are additional sequences affect-
ing splicing efficiency, referred to as exonic or intronic 
splicing enhancers (ESE or ISE), and exonic or in-
tronic silencers (ESS or ISS) (Pastor et al. 2009, Ward 
& Cooper 2010). 
 A growing number of diseases appear to rise 
due to altered splicing, the result of mutations within 
enhancer and/or silencer sequences.  Such mutations 
may reduce the efficiency with which a constitutive 
exon is spliced or affects alternative splicing patterns, 
leading to missplicing and typical skipping, activation 
of cryptic splice sites, or intron retention (Ward & 
Cooper 2010). A number of diseases have been re-
ported to result from intronic mutations. For example, 
a mutation in intron 20 of familial dysautonomia (FD) 
gene was associated with FD (Slaugenhaupt et al. 
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2001); two mutations in introns 4 and 14 of adenoma-
tous polyposis (AP) coli gene with familial AP 
(Neklason et al. 2004, Tuohy et al. 2010); a single 
polymorphism in intron 30 of neurofibromatosis 1 
gene with neurofibromatosis type 1 (Raponi et al. 
2006); and a mutation in intron 9 of the Wilms’ tumor 
1 gene with Frasier’s syndrome (Melo et al. 2002).  In 
addition, work from us and others has shown size 
length variants of intron 4 of the human surfactant pro-
tein B gene (SP-B; Gene ID: 6439; Locus tag: 
HGNC:10801; MIM: 178640) to associate with respi-
ratory distress syndrome (RDS), and other pulmonary 
diseases, either alone or in combination with the pres-
ence of specific SP-A variants (Floros et al. 1995, 
2001, Hamvas et al. 2005, Kala et al. 1998, Lin et al. 
2005, Rova et al. 2004, Seifart et al. 2002a). 
 SP-B is essential for maintaining normal sur-
face tension at the air–liquid interface in the alveolus 
of the lung. The absence of SP-B is incompatible with 
life, and deficiency of SP-B protein compromises lung 
function (Gower & Nogee 2011, Nesslein et al. 2005, 
Tokieda et al. 1997). SP-B protein also maintains al-
veolar epithelial integrity and inhibits endotoxin-
induced lung inflammation (Gower & Nogee 2011, 
Wert et al. 2009). Studies in heterozygous SP-B (+/-) 
mice have demonstrated that a reduction in SP-B asso-
ciates with decreased lung compliance, affects pulmo-
nary mechanics, alters lung function, and increases 
susceptibility to lung injury caused by hyperoxia 
(Nesslein et al. 2005, Tokieda et al. 1997, 1999).  Both 
animal and clinical studies have shown associations of 
reduced SP-B levels with airway infection, indicating 
that infection by a variety of airway pathogens can in-
duce changes in lung structure and function via reduc-
tion of SP-B expression (Beers et al. 1999, Kerr & Pa-
ton 1999). 
 The SFTPB (SP-B) gene maps on the short 
arm of chromosome 2, spans a 9.7kb region, and con-
sists of 11 exons, of which exon 11 contains the 3’ un-
translated region.  Ten exons are transcribed into one 
mRNA of about 2 kb of length that directs the synthe-
sis of a 381 amino acid lung-specific, hydrophobic 42 
kDa SP-B preproprotein. The mature SP-B protein is 
encoded by exons 6 and 7, yielding a 79 amino acid, 
8.7 kDa protein (Guttentag et al. 1998, O'Reilly et al. 
1989, Serrano et al. 2006, Weaver 1998, Weaver et al. 
2002). A length polymorphism in intron 4 has been 
identified (Floros et al. 1995, Hamvas et al. 2005, Lin 
et al. 2005). The variable region is localized approxi-
mately in the first half of intron 4. This region is proxi-
mal to the 5’ss of intron 4 and is characterized by the 
presence of 11 stretches of CA–repeat rich motifs, in 
which more than 65% of the nucleotides are CAs.  
Each motif consists of two elements; a relatively con-
served sequence of approximately 20bp, followed by a 
variable number of CA repeats (Floros et al. 1995, 
Hamvas et al. 2005). At least 8 deletions and 11 inser-
tions have been identified in this CA-repeat-rich region 
(Floros et al. 1995, Hamvas et al. 2005, Lin et al. 
2005). 
 Although SP-B intron 4 length variants have 
been shown to associate with neonatal RDS (Floros & 
Fan 2001, Floros et al. 1995, 2001, Hallman et al. 
2002, Hamvas et al. 2005), bronchopulmonary dyspla-
sia (Rova et al. 2004), chronic obstructive pulmonary 
disease (Seifart et al. 2002a), and lung cancer (Ewis et 
al. 2006, Lin et al. 2005, Seifart et al. 2002b), the con-
tribution of intron 4 size variation to the development 
of these conditions has not been yet elucidated. Motifs 
of CA-repeat-rich variants of SP-B intron 4 have been 
proposed to alter RNA splicing, a process necessary 
for normal gene expression (Lin et al. 2005, Rova et 
al. 2004). Study of several naturally occurring deletion 
mutants has indicated that SP-B intron 4 deletion vari-
ants affected SP-B mRNA splicing (Lin et al. 2005).  
Each motif in SP-B intron 4 contains a fairly con-
served GC rich sequence and various lengths of CA 
repeats (3-17 CAs).  These motifs may contain either 
important ISE or ISS sites for binding of splicing regu-
latory proteins or play key roles in maintaining RNA 
structural stability. In addition, several recent reports 
indicate that RNA secondary structure may play an 
important role in determining the binding of proteins 
to RNA sequences (Buratti & Baralle 2004).   
 In the present work, we investigated the hy-
pothesis that deletion of one or more of the intron 4 
motifs leads to the direct loss of cis-acting ISE or ISS 
and/or to a change of the secondary structure stability, 
resulting in altered SP-B ratio of completely to incom-
pletely spliced RNA. Towards this, we studied the role 
of intron 4 motifs in a systematic way. First, SP-B in-
tron 4 sequence (WT) was identified and used to gen-
erate SP-B minigene constructs (n=24) by removing 
motifs one by one from either the 5’ or the 3’ ends of 
the CA-repeat-rich region of intron 4. Next, the ratio of 
completely to incompletely spliced minigene RNAs 
was investigated by Northern blot and Real-time RT-
PCR after transfection of cells. Motif 8 of intron 4 in-
creased the splicing ratio, and interacted with nuclear 
trans-acting factors in a sequence-specific manner.  
Further in silico analysis of secondary structure stabil-
ity of selected minigene RNAs (with and without motif 
8) and comparison of secondary structures with their 
respective ratios indicated that both specific sequences 
and RNA stability may affect splicing of SP-B intron 
4. 
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Materials and Methods 
 
Oligonucleotides and constructs 
All oligonucleotides used in the present study are 
listed in Table 1S.   
 
WT intron 4 pGEM-T construct 
First, because differences were reported within the mo-
tif-containing intron 4 sequence (Floros et al. 1995, 
Hamvas et al. 2005, Lin et al. 2005, Pilot-Matias et al. 
1989), we sought to identify the most frequently found 
sequence, which we refer to as WT. A 547 bp fragment 
of the SP-B gene intron 4 region was amplified from 
genomic DNAs isolated from blood samples obtained 
from 21 individuals, including 11 patients with RDS 
and 10 healthy control subjects that had been previ-
ously identified as having a complete intron 4 (without 
any naturally occurring deletions). Two independent 
PCRs were carried out for each sample, and the PCR 
products were cloned into the pGEM-T vector as de-
scribed below. Reactions were carried out with 0.1 
mM dNTPs, 50 ng of DNA, 40 ng of each primer, 1X 
buffer mix, 0.63 mM MgCl2 and 1 U of high fidelity 
Taq polymerase (Roche, IN, USA). The PCR products 
(547 bp) included all 11 motifs and were generated by 
using primers, 2051 (starting at nt 2583 of human SP-
B mRNA, GenBank: M24461.1, containing the NheI 
restriction site) and 2052 (starting at nt 3099, contain-
ing the AflII restriction site) (Table 1S). The PCR cy-
cles were:  95°C for 2 min, 35 cycles of 95°C for 30 s, 
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Figure 1. SP-B intron 4. Alignment of the human SP-B intron 4 sequence used in this study (top sequence) and the reference 
intron 4 sequence from GenBank (NG_016967). There are 836 nt in the SP-B intron 4 and the length variation polymorphism is 
localized approximately in the first half of the intron 4 sequence.  This region is 78 nt away from the 5’ss in intron 4 and is char-
acterized by the presence of 11 stretches of CA–repeat rich motifs.  Each motif consists of two elements, a relatively conserved 
18-20 bp sequence (solid underline), followed by a variable number of CA repeats (dashed underline). The 46-bp next to motif 
11 is also underlined (solid underline).  The 5’ splicing site (5’ss), 3’ splicing site (3’ss) and the branch point site are double 
underlined. The variant motifs are depicted in black as “motif 1” etc. on the top of their respective conservative sequence ele-
ment. A NotI site (dotted line) and an EcoRI site (located between positions 78-79 of the intron 4 sequence, not shown) were  
inserted for cloning purposes. 
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Figure 2. Description of the SP-B intron 4 and schematic representation of the intron 4 deletion constructs. Panel A depicts a 
schematic representation of the deletion constructs of intron 4 motifs.  Two series of intron 4 deletion constructs were generated 
via systematic deletion of motifs either from the 5’ end or the 3’ end of the motif region. The WT contains all 11 motifs plus a 
46 bp sequence (grey box) at the 3’ end of motif 11. Compared to the WT, the sequence of motif 1 is deleted in construct A. In 
construct B, the sequence of motifs 1 and 2 are deleted, etc., as shown diagrammatically. The various intron 4 deletion frag-
ments shown range in size from 46-417 nt.  These were cloned in a pGEM-T vector, and then inserted between the EcoRI and 
NotI sites of pcDNA3.1 minigene Del-m construct, as shown in Panel A. The pcDNA3.1 minigene Del-m was obtained by 
modifying the previously generated pcDNA3.1 pBi4normal (Lin et al. 2005) as described in Materials and Methods. MCS up-
stream/downstream of the SP-B sequence were removed by site-directed mutagenesis and the EcoRI and NotI cloning sites were 
generated. EcoRI is located 78 nt from the end of exon 4 and NotI is located 502 nt upstream from the beginning of exon 5.  
Panel B depicts the variable region of the SP-B intron 4 WT sequence as identified in this study. This region has been character-
ized previously (Floros et al. 1995) and shown to consist of 11 motifs with each motif consisting of two elements, a relatively 
conserved sequence (bold) followed by a variable number of CA repeats (italics). 
56°C for 60 s, 72°C for 1 min, and 72°C for 5 min. 
 The PCR product was separated on a 0.8% (w/
v) agarose gel, purified and subjected to an overnight 
ligation at 16°C with the pGEM-T vector in a reaction 
containing 1X rapid ligation buffer, 50 ng of pGEM-T 
vector (Promega, WI, USA), 25 ng of purified PCR-
product and 3 U of T4 DNA ligase. Transformation 
was carried out using JM109 E. Coli competent cells 
(Promega, WI, USA). Recombinant plasmid DNA was 
prepared using the Qiagen Miniprep kit (Qiagen, CA, 
USA) and digested with AflII and NheI.  A total of 57 
clones were sequenced, and of these 39 (68%) had the 
same intron 4 sequence, referred here as intron 4 WT. 
These 39 clones were derived from 13 genomic sam-
ples (8 from RDS patients and 5 from controls).  Seven 
of the remaining studied samples showed variation in 
the number of CA repeats in motifs 1 and 3, and one 
had a sequence identical to that of the reference se-
quence M24461. The WT SP-B intron 4 sequence was 
aligned and compared with the GenBank reference 
sequence (accession no. M24461) using the Clustal W 
multiple Alignment program from Bioedit version 
7.0.5 (Figure 1). 
 
pcDNA 3.1 SP-B minigene Del-m construct 
A diagrammatic representation of the sequence of the 
11 motifs and the deletion intron 4 constructs, along 
with the pcDNA 3.1 SP-B minigene Del-m, are shown 
in Figure 2. The pcDNA 3.1 SP-B minigene Del-m 
was generated by removing the 11 CA-repeat-rich mo-
tifs of SP-B intron 4 by modifying the parent plasmid 
pcDNA 3.1 pBi4normal (Lin et al. 2005) that con-
tained the region starting at 8 bp upstream of the ATG 
start codon in exon 1 and ending at 433 bp down-
stream of exon 6. To remove the 11 motifs, the 
pBi4normal was modified as follows: First, MCS 
(multiple cloning sites) upstream/downstream of the 
SP-B sequence in pBi4normal were removed with 
primers 1816/1817 and 1818/1819 (Table 1S) by Site 
Directed Mutagenesis (Quick-changeII XL Kit, 
Agilent).  Second, new restriction sites for EcoRI and 
NotI were created by Site Directed Mutagenesis 
(Quick-changeII XL Kit, Agilent) with primers 
1811/1812. Third, the 11 motifs, including a 46-bp 
oligonucleotide in the 3’ end of the eleventh motif, 
were sequentially removed.  Of note, there is a 78 bp 
of intron 4 sequence between the 5’ splicing site and 
motif 1 that contains a CA-repeat region between nu-
cleotides 68-78 (Figure 1).   
 
pcDNA 3.1 SP-B minigene constructs A-I & L0-T 
All minigene constructs include the first 6 exons, 4 
introns (1, 2, 3, 5) and part of intron 4, as shown in 
Figure 2A.  A series of minigene constructs were made 
by deletion of motifs from either the 5’ or 3’ end. All 
inserts, including the WT and the deletion fragments 
with different lengths of motifs of SP-B intron 4, were 
amplified using the pGEM-T WT intron 4 as a tem-
plate; the primers used for the amplification are shown 
in Table 1S.   
 PCR was carried out in 1X High Fidelity 
Buffer, 2 mM MgSO4, 0.2 mM of each dNTP, 100 ng 
of each primer, and 1 U of Platinum Taq High Fidelity 
(Invitrogen, CA, USA). To improve the specificity of 
amplification in order to generate different length vari-
ants, the following touchdown PCR program (Korbie 
& Mattick 2008) was used: 95°C for 2 min, 5 cycles of 
95°C for 30 s, 70°C for 30 s and 68°C for 30 s, then 5 
cycles of 95°C for 30 s, 68°C for 30 s and 68°C for 30 
s, and then 5 cycles of 95°C for 30 s, 66°C for 30 s and 
68°C for 30 s, followed by 25 cycles of 94°C for 30 s, 
64°C for 30 s and 68°C for 30 s and a final extension 
step at 68°C for 5 min.  All PCR fragments, ranging 
from 96 to 437 were separated on agarose gel, purified 
and cloned into a pGEM-T vector (Promega, WI, 
USA).  The recombinant plasmid DNAs were digested, 
purified and sub-cloned into the EcoRI and NotI sites 
of pcDNA 3.1 minigene Del-m (Figure 2A, inset). 
 
pcDNA 3.1 SP-B minigene K, U, motif 3, 4, 3+4, 8, 9, 
and 8+9 constructs 
The constructs containing only motif 1 (minigene U), 
motif 3, motif 4, motifs 3+4, motif 8, motif 9, motifs 
8+9 or the 46-bp sequence at the 3’ end (minigene K) 
were generated by annealing two oligonucleotides and 
cloned into the EcoRI and NotI sites of pcDNA 3.1 
minigene Del-m. 
 
pGEM-11ZM8-D(CA) construct 
To obtain motif 8 probes for RNA electromobility shift 
assays (REMSA), two oligos (2053/2054, Table 1S) 
were synthesized, annealed, and digested with EcoRI 
and NotI. The insert was cloned into the pGEM-11Z 
vector (Promega, Madison, WI, USA) to allow in vitro 
transcription under the T7 promoter.  The CA-repeat-
rich region was removed by site directed mutagenesis 
to obtain transcripts with the conserved sequence of 
motif 8 (i.e. without CA-repeats). 
 
pGEM-11Z M8(G4)-D(CA) construct 
A potential binding sequence element for SRp20 in 
motif 8 (CATC) was mutated, in the pGEM-11Z M8-D
(CA) construct  by site directed mutagenesis, using 
oligos 2061/2062 (Table 1S), and replaced by GGGG.  
The new construct was used as a template to generate 
negative control probes for REMSA. 
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Northern blot and RT-PCR related methods 
 
Generation of probes 
Two constructs were used to synthesize probes for 
Northern blot analysis: the pGEM-E3 that contained 
exon 3 sequences to detect total SP-B RNA and pGEM
-I4 that contained intron 4 sequences to detect only 
incompletely spliced RNA or pre-mRNA. The probes 
exon 3 (probe-E3), consisting of 268 nucleotides of 
exon 3 (position 2060 of GenBank reference sequence 
M24461) and intron 4 (probe-I4), consisting of 275 
nucleotides of intron 4 (position 3162 of reference se-
quence M24461) were generated by PCR using the 
WT minigene as template and primers 1836/1837 and 
1858/1859, respectively.  The PCR cycling conditions 
were 95°C for 2 min, 34 cycles of 95°C for 40 s, 58°C 
(probe-E3), or 61°C (probe-I4) for 30 s and 72°C for 
30 s, followed by a final extension step at 72°C for 10 
min. The PCR products were cloned into pGEM-T 
vector, resulting in pGEM-E3 and pGEM-I4. These 
were used to generate RNA probes (probe-E3, probe-
I4) by in vitro transcription using a Northern blot 
starter kit (Roche, Indianapolis, IN, USA). 
 
DNA Sequencing 
All constructs were confirmed by sequence analysis 
using an Applied Biosystems ABI 377 DNA sequencer 
at the Molecular Genetics Core Facility, The Pennsyl-
vania State University College of Medicine. 
 
Cell Culture 
The mammalian CHO (Chinese hamster ovary)-K1 
cell line, purchased from the American Type Culture 
Collection (ATCC #CCL-61, VA, USA), was used for 
transfection.  Cells were grown in GMEM (Glasgow 
Minimum Essential Medium; Invitrogen, Carlsbad, 
CA) supplemented with 10% (v/v) FBS (fetal bovine 
serum; Hyclone, UT, USA), 1X antimycotic/antibiotic 
solution (Sigma, MO, USA), 1x G+A (100× stock: 6 
mg/ml L-glutamic acid and 6 mg/ml L-asparagine), 1X 
nucleoside mixture (Invitrogen, Carlsbad, CA) and 1X 
sodium pyruvate (Invitrogen, Carlsbad, CA), cultured 
at 37°C in a 5% (v/v) CO2 atmosphere and subcultured 
weekly in 10-cm dishes to 50-80% confluence. 
 
Transient transfection  
CHO-K1 cells were used in a previous relevant work 
(Lin et al. 2005) and in this study. A preliminary ex-
periment showed that no human SP-B mRNA homo-
logue was detected by Northern blot and no PCR prod-
uct was amplified by RT-PCR with human SP-B-
specific primers from control CHO-K1 cells (data not 
shown). Cells were plated into 6-well culture plates 
until 50–80% confluence. A time course (5, 18, 24, 30, 
36, 42 hr) with WT and minigenes L0 and N as well as 
a concentration course (0.5, 1, 2.5, 5.0, 10.0 μg) with 
minigene L0 and Del-m were carried out in CHO-K1 
cells (Figure 1S) to identify optimal conditions for 
transfection of the constructs under study. The 30-36h 
time point and a concentration of 2.5 μg were chosen 
for further experimentation. The CHO-K1 cells were 
transfected with the Lipofectamine LTX Reagent kit 
(Invitrogen, Carlsbad, CA) following the manufac-
turer’s protocol.  
 
RNA Isolation  
RNA was extracted using the RNA Bee solution (Tel-
Test, FL, USA), precipitated in isopropyl alcohol, 
washed with 75% ethanol and resuspended in RNase-
free water.  Purity and concentration of extracted RNA 
was determined by Nanodrop 1000 spectrophotometer.  
Integrity of the RNA was also confirmed by gel elec-
trophoresis by the presence of 28S and 18S ribosomal 
RNA bands. 
 
Northern blot analysis 
Samples of total RNA (5 μg from transfected cells), as 
well as RNA markers (Promega, WI, USA), were incu-
bated with loading dye for 30 min at 65°C, and loaded 
on a 1% (w/v) agarose gel containing formaldehyde 
37% (v/v). Samples were then separated by electropho-
resis and transferred onto a positively charged nylon 
membrane (Roche, IN, USA). The blot was cross-
linked using a UV Stratalinker 2400 (Stratagene, CA, 
USA). The RNA marker (Promega, WI, USA) was 
used to estimate the size of SP-B transcript bands on 
the Northern blots. The gel and the membrane were 
photographed under UV light. 
 For the detection of completely and incom-
pletely (containing intron 4 sequences) spliced RNA, 
DIG-labeled SP-B antisense RNA probe-E3 and probe
-I4 were used, respectively. Hybridization was per-
formed in DIG Easy Hyb Buffer (100 ng DIG-labeled 
RNA probe/ml) for 12 hours at 68°C. The blot was 
washed (DIG Wash and Block Buffer Set, Roche, IN, 
USA), bands were detected by exposure to film at RT, 
1-5 min, and the band density was quantified by densi-
tometry using a Molecular Dynamics model 100A 
Scanner (Amersham Pharmacia Biotech). 
 
Real-time RT-PCR 
All RNA samples were treated with DNA-free DNase 
Treatment & Removal Kit (Ambion, TX, USA). One 
step Real-time RT-PCR was performed using the 
Taqman One-Step RT-PCR Master Mix Reagents Kit 
(Applied Biosystems, NJ, USA). Completely spliced 
mRNA was detected with primers 1856/1857 and 
probe Vic1 [TaqMan VIC/minor groove binding 
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(MGB) probe] specific for the unique junction site of 
Exon 4 and Exon 5. For incompletely spliced RNA, we 
used primers 1854/1855 and probe Fam1 (TaqMan 
FAM/MGB probe) that specifically amplify the junc-
tion part of Intron 4 and Exon 5 (Table 1S). Reference 
samples for pre-mRNA and mRNA were plasmids 
pcDNA 3.1 SP-B WT minigene and pEE14-SP-B 
cDNA (Wang et al. 2003), respectively; these were 
serially diluted to generate standard curves. All reac-
tions were carried out with 5 μl of template RNA/
DNA, 300 nM of each primer, 250 nM MGB TaqMan 
probe, 1× Master Mix (Applied Biosystems, NJ, USA), 
1× MultiScribe and RNase inhibitor mix (Applied Bio-
systems, NJ, USA). The following Real-time RT-PCR 
thermal cycler conditions were used: 48ºC for 30 min 
(cDNA synthesis) and 95ºC for 10 min, followed by 42 
cycles at 95ºC for 15 s (denaturation) and 60ºC for 1 
min (annealing/extension). Reactions were performed 
on an ABI PRISM 7900 Sequence Detection System 
(Applied Biosystems, NJ, USA). The relative expres-
sion level for each construct was determined by the 
average value from three independent experiments. 
RNA target quantity was calculated by the Relative 
Standard Curve Methods (Applied Biosystems). Ex-
periments were repeated 3 times (n=3). 
 
REMSA- associated methods 
 
SRp20 protein expression 
In order to obtain nuclear extracts that contained hu-
man SRp20 protein for gel shift assays, we transiently 
expressed SRp20 in CHO-K1 cells. In brief, cells at 
60% confluence were transfected with 6 μg/dish 
(10cm) of a vector containing the human SRSF3 
cDNA (Homo sapiens arginine-rich splicing factor 3 
transcript variant 1) (Origene, Rockville MD, USA) 
that encodes SRp20 protein. Transfection was per-
formed with the TurboFectin 8.0 (Origene, Rockville 
MD, USA) reagent diluted with Opti-MEM I 
(Invitrogen, Carlsbad, CA, USA), and transfected cells 
were incubated for 36 h at 37°C, as described above. 
 
Nuclear Fractionation 
Nuclear extracts from SRSF3 (SRp20) transfected and 
non-transfected CHO-K1 cells were obtained using the 
NE-PER Nuclear and Cytoplasmic Extraction kit 
(Thermo Scientific, Rockford IL, USA), after harvest-
ing with PBS and cell scraping.  Protein concentration 
was determined by the BCA Protein Assay (Thermo 
Scientific, Rockford IL, USA), following the manufac-
turer’s instructions. 
 
Western blot 
Western blots were performed to confirm expression 
of SRp20 in nuclear extracts. Four different antibodies 
(Abs) from two different vendors were tested. Ab 1 
was a rabbit polyclonal Ab in which the immunogen 
was a synthetic peptide derived from an internal region 
of human SFRS3 (Abcam, Cambridge, MA, USA); Ab 
2 was a mouse monoclonal Ab in which the immuno-
gen was the amino acids 1-85 region of human SFRS3 
(Abcam); Ab 3 was a rabbit polyclonal Ab in which 
the immunogen was the N terminal amino acids 35-84 
region of human SFRS3 (Abcam); Ab 4 was a mouse 
monoclonal Ab in which the immunogen was the 
amino acids 1-85 region of human SFRS3 (Abnova, 
Walnut, CA, USA). Anti-SFRS3 primary Abs were 
used at 1:500 dilution, followed by incubation with 
goat anti-rabbit or anti-mouse IgG (H+L)-HRP conju-
gate (Biorad, Hercules CA, USA), 1:3000 dilution.  
HRP was detected by luminol-based chemilumines-
cence ECL Western Blotting Substrate (Thermo Scien-
tific, Rockford IL, USA). 
 
In vitro transcription 
RNA probes for REMSA experiments were synthe-
sized in vitro with the AmpliScribe T7-Flash Biotin-
RNA Transcription Kit (Epicentre, Madison, WI, 
USA) using the plasmid M8-D(CA) and the mutated 
plasmid M8(G4)-D(CA). These were linearized by 
NotI and served as templates, following the manufac-
turer’s protocol.  In brief, a reaction containing 110 ng 
of linear plasmid DNA, 1X transcription buffer, 9 mm 
NTP / Biotin-UTP PreMix, 10 mM DTT, 0.5 μl Ri-
boGuard RNase Inhibitor, and 10 U of polymerase 
enzyme were incubated at 37ºC for 1 h.  One unit of 
DNase I (Epicentre, Madison, WI, USA) was then 
added and incubated at 37°C for another 15 min to re-
move the DNA template.  Unlabeled probes were pre-
pared likewise using 9 mM of non-biotinylated NTPs.  
RNA transcripts were purified using RNA-bee (TEL-
TEST, Friendswood, TX, USA) in conjunction with 
Direct-zol RNA miniprep columns (Zymo Research, 
Irvine, CA, USA). 
 
REMSA 
Biotinylated RNA transcripts were heated at 80°C for 
20 min and rapidly cooled on ice for 1 min prior to 
incubation with nuclear protein extracts. Each binding 
reaction contained 10 mM HEPES pH 7.3, 20 mM 
KCl, 1 mM MgCl2, 1 mM DTT, 1% (v/v) glycerol, 40 
U of RNaseOUT recombinant ribonuclease inhibitor 
(Invitrogen, Carlsbad, CA, USA), 2 μg of tRNA as a 
non-specific competitor, 200 nM of in vitro transcribed 
biotinylated RNA, and 1μg of nuclear extract. Reac-
tion mixtures were incubated at room temperature 
(RT) for 20 min, prior to loading on the gel.  For com-
petition shift assays, a 100- to 300-fold mass excess of 
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unlabeled in vitro M8-D (CA) and M8(G4)-D(CA) 
RNA transcripts were used to compete specific interac-
tions between RNA and nuclear extracts. Unlabeled 
probes were incubated with protein extracts at RT for 
10 min prior to the addition of biotinylated probe. The 
biotinylated M8 (G4)-D(CA) RNA probe was used as 
a negative control. 
 Samples were fractionated on native 6% poly-
acrylamide gels in 1X TBE and transferred to posi-
tively charged nylon membranes (Roche, Indianapolis, 
IN, USA) using a semidry Amersham Biosciences 
Nova blot apparatus in 1X TBE at 400mA for 30 min.  
Membranes were exposed to UV (254 nm) 120 mJ/cm2 
for 45 sec (Spectrolinker XL-1000 UV crosslinker, 
Spectronics Corporation, New Cassle, NY, USA) for 
crosslinking. Band shifts were detected using the 
Chemiluminescent Nucleic Acid Detection Module 
(Thermo Scientific, Rockford IL, USA). 
 For identification of SRp20:RNA M8-D(CA) 
interaction on REMSA, 1-2 μg of SRFS3 Ab were 
added to the binding reactions for supershift assays.  
Ab and nuclear extracts were incubated at RT for 20 
min to form a protein-Ab complex which was then 
added to the RNA binding reaction. Four different 
Abs, as described above, from two different vendors 
were tested. 
 
Statistical Analysis 
All experiments were repeated at least three times as 
stated in the results section and triplicate assays were 
performed for each experimental sample. The data 
were analyzed by the SigmaStat software (version 3.5). 
Differences among groups were assessed by ANOVA 
or multiple-comparison ANOVA (Tukey's test). Re-
sults are expressed as means ±SE. Statistically signifi-
cant differences were considered when p< 0.05. 
 
In Silico Prediction Analysis  
 
Branch point 
To search for the predicted branch point of splicing 
sites of intron 4, we used an online program: the Hu-
man Splicing Finder website Version 2.4.1(University 
of Montpellier, France, http://www.umd.be/HSF/) 
(Desmet et al. 2009), which was created to help the 
study of pre-mRNA splicing.   
 
Prediction of RNA secondary structure 
To study differences in secondary structure among SP-
B intron 4 regions of all constructs, we used the RNA-
fold online program (http://rna.tbi.univie.ac.at/, Insti-
tute for Theoretical Chemistry, University of Vienna, 
Austria) (Mathews et al. 1999) to predict the secon-
dary structures of intron 4 variants. This software fol-
lows the algorithm published by Zuker and Stiegler 
(Zuker & Stiegler 1981) to estimate the minimum total 
base pair distance of the RNA secondary structure and 
the minimum free energy at 37°C. The centroid secon-
dary structure, with the best possible combination of 
paired bases, and the minimum free energy (dG) nor-
malized for size by dividing dG by the total number of 
bases of each sequence under study, was obtained for 
the experimental intron 4 variant sequences. 
 
Results 
 
SP-B intron 4 motifs and minigene constructs 
The sequence of intron 4 contains 11 motifs, each con-
sisting of a relatively conserved sequence and a CA-
repeat-rich region (Floros et al. 1995, Hamvas et al. 
2005, Lin et al. 2005, Pilot-Matias et al. 1989). We 
sequenced 57 genomic clones from 21 individuals to 
identify the most frequently observed intron 4 se-
quence, which is referred to here as WT intron 4 se-
quence and was used in the present study. The WT 
sequence, when compared to the Genbank reference 
sequence (Figure 1), was nearly identical except that 
the Genbank sequence lacked 6 nucleotides in motif 10 
(positions 402-408).   
 The Human consensus BP site, shown to be 
yUnAy, followed by poly pyrimidines tracts, was iden-
tified for intron 4 using the Human Splicing Finder 
program (Desmet et al. 2009). The underlined BP se-
quence (Figure 1) exhibited consensus values >70% 
(79.98%), and had a good position according to the 
AG dinucleotide exclusion zone (Gooding et al. 2006).  
The bold A is located 32 bp upstream of the 3’ss. 
 The intron 4 WT pGEM-T recombinant con-
struct (see Materials and Methods) was used to gener-
ate a series of deletion constructs with motifs being 
removed one by one from either the 5’ or the 3’ end of 
the CA-repeat-rich region, as illustrated in Figure 2A, 
and cloned between the EcoRI and Notl sites of the Del
-m minigene vector. The SP-B minigene Del-m 
(Figure 2A) that had all 11 motifs removed was gener-
ated as described in the Materials and Methods section. 
Twenty four SP-B minigene constructs containing a 
different number of motifs were studied. These were 
the WT SP-B minigene (normal-sized intron 4 with 
EcoRI and NotI sites) and the 23 SP-B minigene vari-
ant constructs (i.e. intron 4 deletions of varying size). 
 A schematic representation of the constructs 
and their missing motifs is shown in Figure 2A, and 
the sequence of each motif is shown in Figure 2B. The 
deletions were located within a 417 bp sequence of 
intron 4, found approximately in the first half of intron 
4, nucleotides 79-496. This 417 bp region is a CA-
repeat-rich region in which 65% of the total number of 
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Figure 3. Northern blot and real-time RT-PCR analysis of SP-B minigene mRNAs. Panel A shows examples of Northern blot 
data with probe-E3, for constructs A-K (i) and L0-U (ii), respectively. Panel B shows examples of Northern blot data with probe
-I4, for constructs A-K (i) and L0-U (ii), respectively. In addition to the deletion mutants, WT and Del-m were also included.  
Two bands were observed with probe-E3 (Panel A); a lower band with high intensity and an upper band with low intensity.  The 
lower band represents normal mRNA and the upper band incompletely spliced RNA. With probe-I4, one band was observed 
(Panel B) representing incompletely spliced RNA. Panel C shows densitometric analyses of  Northern Blot experiments for con-
structs A-K (i) and L0-U (ii), respectively. Panel D shows real-time RT-PCR results for constructs A-K (i) and L0-U (ii), re-
spectively.  The graphs show the ratios of normal mRNA/incompletely spliced RNA. The ratio of the WT minigene was set to 
1.0 and all the relative ratios were evaluated based on the WT value (e.g. relative ratio of A in Northern Blot is 0.784), and the 
average ± SE is shown.  Both the amount of normal mRNA and of incompletely spliced RNA were determined as described in 
Materials and Methods. Experiments were repeated 3 times (n=3) and each sample was assayed in triplicate. 
nucleotides are CAs. These CAs are clustered in 12 
stretches of CA repeats. These included CA repeats 
within the 11 motifs and one within nucleotides 68–78, 
prior to the start of the 11 motifs. As shown in Figure 
2B, motifs 1, 3, 9, and 11 had long CA repeats (10-17 
CAs), and motifs 6, 7, and 8 had long conserved se-
quences (20-22 nt). In the other motifs (except motifs 
10 and 11), the CA repeats were 18 nt long. Motif 10 
had a truncated conserved sequence (3 nt) and motif 11 
had a short sequence (14 nt). 
 
Expression of SP-B minigenes in CHO-K1 cells 
 
Northern blot analysis 
Figure 3 depicts examples of Northern Blot analysis of 
all constructs. When the SP-B exon 3 probe (probe-E3) 
was used, all minigene constructs, including the WT, 
expressed a visible variable amount of incompletely 
spliced RNA in addition to normal mRNA bands 
[Figure 3A (i) and 3A (ii)].  When the probe contain-
ing only part of the second half of intron 4 sequence 
was used (probe-I4), only one band was observed, 
which had the same size as that of the incompletely 
spliced RNA [Figure 3B (i) and 3B (ii)]. To compare 
the efficiency of RNA splicing, we calculated the ra-
tios of the amount of normal mRNA to incompletely 
spliced RNA (Figure 3C) for each minigene construct 
shown in Figure 2A.  The ratio from the WT minigene 
was set to 1.0, and all the relative ratios were evaluated 
based on the WT value. 
 Although the total amount of DNA transfected 
and the RNA concentration loaded on the gel was the 
same as those of the WT, the relative ratios differed.  
Figures 3C (i) and 3C (ii) show that the relative ratio 
of minigene Del-m was the lowest (around 0.4), and all 
other relative ratios varied from 1.0 to 0.4, with the 
WT minigene expressing the highest relevant amount 
of completely spliced RNA. The ratios between WT 
and N had no significant difference [Figure 3C (ii)].  
Several constructs exhibited levels similar to Del-m.  
These included minigenes C and H [Figure 3C (i)], and 
L0, L, M, O, P, Q, R, S, T, and U [Figure 3C (ii)].  
Comparison of adjacent motifs showed that the ratios 
of minigene WT, B, G, K, or N, decreased sharply 
once motif 1, 3, 8, or the sequence (46 nt) at the 3’ end 
of motif 11 was removed (p<0.01), while the ratios of 
minigene C, H, or M, increased once motif 4 or 9 was 
removed (p<0.01) [Figures 3C (i) and 3C (ii)].   
 
Real-time RT-PCR analysis  
To further assess expression and confirm Northern blot 
results, we used Real-time RT-PCR to quantify com-
pletely and incompletely spliced RNA [Figure 3D (i) 
& 3D (ii)].  The relative ratio of the WT minigene was 
set to 1.0, and with 2 exceptions, the RT-PCR ratios 
were similar to those from Northern blot [Figures 3C 
(i) and 3C (ii)]. Real-time RT-PCR showed that a) re-
moval of motifs 3 & 4 did not change the ratio be-
tween minigene B/C and minigene C/D as shown by 
Northern blot analysis; and b) the ratio decreased 
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Figure 4. Northern blot and real-time RT-PCR analysis of selected motifs. Panels A and B show the results of Northern blot and 
real-time RT-PCR, respectively, for constructs containing selected motifs, M3, M4, M3+4, M8, M9, M8+9, including WT and 
Del-m. The ratios of normal mRNA/incompletely spliced RNA are shown. The amount of both normal mRNA and incompletely 
spliced RNA was determined as described in Materials and Methods. Experiments were repeated 3 times (n=3) and each sample 
was assayed in triplicate.  Bars show mean±SE. 
sharply from minigene T to U once motif 2 was re-
moved (p<0.05) while there was no difference in the 
ratios by Northern blot analysis [Figure 4C (ii)].  Re-
moval of motif 8 from minigene G or N, and removal 
of the 46 nt sequence at the 3’ end of motif 11, resulted 
in a significant decrease of the ratios, whereas removal 
of motif 9 from minigene H or M resulted in an in-
crease of the ratio, as shown by Northern blot analysis.   
 
Effect of selected motifs on splicing 
Based on the experimental findings (Figure 3C, 3D), 
selected motifs were studied for their role on splicing, 
individually or in combination with their adjacent mo-
tif.  Six constructs were generated as described in Ma-
terials and Methods, where each contained motifs 3, 4, 
3+4, 8, 9, or 8+9. The impact of these motifs on splic-
ing was studied by Northern blot analysis and Real-
time RT-PCR.  The rationale for studying motifs 8 and 
9 was based on the observation that these consistently 
(by both Northern blot and Real-time RT-PCR) af-
fected the ratio, as indicated by differences among 
constructs, G, H, and I, and of constructs M, N, and O.  
Motifs 3 and 4 on the other hand did not consistently 
show significant differences between RT-PCR and 
Northern blot and were used here for comparison pur-
poses. 
 Figures 4A and 4B depict the relative ratio of 
Northern blot analysis and of Real-time RT-PCR, re-
spectively, of these minigene constructs. Consistent 
findings were observed by both methods (Figures 4A 
and 4B). Compared to the ratio of WT, all ratios, ex-
cept for motif 8, exhibited significant differences 
(p<0.05). Compared to the ratio of Del-m, the ratio of 
motif 8 increased (p<0.05), and the ratio of motifs 9 
and 8+9 did not change significantly, although signifi-
cant changes (p<0.05) were observed between motif 8 
and motif 9.  On the other hand, the ratio among mo-
tifs, 3, 4, and 3+4, did not show any significant 
changes by either method.   
 
Motif 8 generated a sequence-specific electromobil-
ity shift with nuclear proteins; mutation of the 
CAUC→GGGG element abrogated the specific 
shift 
Experimental evidence shown above identified motif 8 
as an important regulatory sequence element.  As proof 
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Figure 5. Motif 8 forms a sequence-specific shift with nuclear extracts. REMSA was performed to study specificity by incubat-
ing 200 nM of biotin-labeled RNA (obtained from construct M8-D(CA)) with 1 μg of nuclear extracts obtained from CHO-K1 
cells in which human SRp20 protein was overexpressed. Lanes 1 and 12 show free probe; lanes 2, 6, and 13 show specific shifts  
that were obtained by incubation of probe and nuclear extracts; lanes 3–5 show competition with 100, 200, and 300- fold molar 
excess of unlabeled M8-D(CA) RNA; lanes 7 and 8 show competition with 200 and 300- fold molar excess of unlabeled mu-
tated M8(G4)-D(CA) RNA; lanes 10 and 11 show the lack of shifts when the mutated probe M8(G4)-D(CA) was incubated with 
nuclear extracts; lanes 14-16 show that inclusion of Abs 1, 2, and 3, respectively, does not abrogate the specific shift; lane 17 
shows competition of the specific shift and an apparent supershift when M8-D(CA) RNA was incubated with nuclear extract 
and 1 μg of Ab 4. Specific shifts (S), and super shift (SS) are labeled. Gel shift experiments were repeated 4 times. 
of principle, we assessed the importance of motif 8, a) 
by carrying out shift assays to study whether sequence-
specific RNA:protein complexes are formed, and b) by 
determining whether one of the binding proteins is 
SRp20. The rationale for the latter was based on the 
fact that motif 8 contains a sequence (CAUC) shown 
recently to be a potential binding site for SRp20 
(SRFS3) (Ankö et al. 2012, Hargous et al. 2006). Al-
though the RNA binding domain of SRp20 proteins is 
conserved among species for REMSA, we used CHO-
K1 nuclear extracts (the cell line used for the transfec-
tion experiments described above) with and without 
transient expression of human SRp20 as described in 
Materials and Methods. Gel shift assays revealed the 
formation of specific RNA:protein complexes (Figure 
5, lanes 2 and 6). The specificity of this interaction 
was confirmed by a) competing with molar excess of 
unlabeled probe sequence (Figure 5, lanes 3-5), b) non
-competition by a mutated probe (GGGG instead of 
CAUC) (Figure 5, lanes 7 and 8), and c) the absence of 
shift with the mutated probe (Figure 5, lanes 10 and 
11). Nuclear extracts from CHO cells that were not 
transiently transfected with the human SRSF3 cDNA 
(SRp20) also formed specific RNA/protein complexes 
(not shown). However, we could not confirm experi-
mentally whether the specific shift contains SRp20. 
Three different Abs targeting SRp20 (Abcam) did not 
disrupt the specific RNA:protein complex or form su-
pershifts when these were included in the shift reaction 
assays (Figure 5 lanes 14-16). Although, a fourth 
SRp20 Ab (Abnova) both abrogated the formation of 
the complex and formed an apparent supershift (lane 
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Figure 6. Predicted secondary structure for the WT intron 4 and of selected deletion intron 4 mutants.  The RNA secondary 
structure of the WT minigene displayed the following characteristics: CA-repeat regions either individually, or with other CA 
rich regions, tended to form stable loops (red color). Among these, the CA repeats from motifs 1 & 9 formed the largest loop.   
On the contrary, the conservative sequences (GC rich) tended to form stems with varying stability. Among these, conserved 
sequences of motifs 3 and 4, as well as motifs 5 and 7, formed two long stems, respectively. The 5’ and 3’ ends are shown by 
red arrows (→).  The black arrow marks the beginning of each motif.  The star (*) marks the beginning of each CA repeat 
within each motif.  The normalized dG of WT is -220.97cal/mol.  The normalized dG for the secondary structure of each spe-
cific minigene is shown.  Differences in the structural stability of stem 1 in minigenes G and H are marked by a box. The nu-
cleotide region (78nt) prior to the start of intron 4 motifs and the nucleotide region (46nt) at the end of intron 4 motifs are noted 
along with the location of each motif. The color scale ranging from 0 (low stability) to 1 (high stability) is shown. 
17), it is unclear whether the specificity of this Ab is 
for the bound proteins(s) or the probe, because a super-
shift was observed when the probe and the Ab (in the 
absence of nuclear extract) were co-incubated (not 
shown). The specificity of the Abs was assessed by 
Western blot analysis. Abs 1, 3, and 4, but not Ab 2, 
identified by Western blot a specific nuclear protein 
with a size of that of the SRp20 protein (not shown).  
Also, mass spectroscopy analysis of the proteins in the 
specific shift did not identify SRp20, although other 
potential splicing factors were identified. 
 
In silico analysis of secondary structures of con-
structs with and without motif 8  
To further gain insight of the potential role of secon-
dary structure stability in the observations made above, 
we analyzed the secondary structures of the WT mini-
gene and of selected deletion mutants, using an online 
available program (RNAfold).  dGs were normalized 
for length (i.e. by the number of nucleotides). The nor-
malized dG for WT was -221 cal/mol and the normal-
ized dGs of all other secondary structure constructs 
varied from -202 cal/mol (minigene B) to -258 cal/mol 
(minigene U) (Figure 6). Analysis of the WT minigene 
structure showed that the CA-repeat region, or CA 
cluster, tended to form a stable loop by itself, or with 
other CA rich regions. While the CA repeats of motif 1 
and motif 9 formed the largest loop (Figure 6), the 
conserved sequences (GC rich) tended to form stems 
with varying stability. Among these, the conserved 
sequences of motifs 3 and 4, as well as motifs 5 and 7, 
formed, between themselves (3 with 4 and 5 with 7) 
two long stems with medium stability, and motifs 1 
and 11 formed a stem with low stability. The intron 4 
motif elements of the minigenes studied here also 
tended to exhibit the same structural characteristics as 
the WT, i.e. CA repeats formed loops and conserved 
sequences formed stems. 
 We next studied pairs of minigenes with and 
without motif 8. We found that: (i) comparison of sec-
ondary structure characteristics of minigenes, M, N, 
and O, revealed that the overall stability of N (dG -229 
cal/mol) was similar to that of the WT (dG -221 cal/
mol) whereas M (dG -209 cal/mol) and O (-242 cal/
mol) were, respectively, less and more stable than N. 
Removal of motif 9 shown to have a negative impact 
on the ratio, resulted in a structure (minigene N) with 
stability similar to that of WT. However, removal of 
motif 8 (from minigene N) generated minigene O that 
had an even more stable structure (dG-242 cal/mol) 
than the WT. Thus, major changes in the overall struc-
tural stability in either direction (away from that ob-
served in the WT) may negatively impact the ratio of 
completely to incompletely spliced RNA. (ii) Mini-
gene G that contained motif 8 and exhibited a higher 
ratio compared to minigene H [Figure 3C (i) and 3D 
(i)], revealed the following: although minigene H had a 
similar stability (dG -238 cal/mol) with minigene G 
(dG -232 cal/mol), a close inspection of their stems 
and loops showed that the “microstability” of a stem 
differed among these 2 minigenes, with minigene H 
showing higher microstability (color scale: 0: lower – 
1: higher) in stem 1 (marked with a square) than G.  
Thus, in spite of a fairly similar overall dG, structural 
“microstability” of distinct elements within each RNA 
may affect differentially various downstream proc-
esses.  
 
Discussion 
 
A number of studies have shown associations of SP-B 
intron 4 variants and pulmonary disease in both infants 
and adults (Floros et al. 1995, Hamvas et al. 2005, Sei-
fart et al. 2002b). Although this variation may alter 
mRNA splicing, RNA stability, or transcription factor 
binding sites necessary for normal gene expression, the 
details of these processes have not been defined (Lin et 
al. 2005, Rova et al. 2004). In this study, we investi-
gated the hypothesis that one or more of the intron 4 
motifs has a positive or a negative impact on SP-B 
RNA splicing. We found that: (i) virtually the entire 
SP-B intron 4 sequence was necessary for normal lev-
els of RNA, although some motifs may be more im-
portant than others; (ii) motif 8 by itself, or with up-
stream motif sequences, exhibited a ratio of com-
pletely to incompletely spliced RNA comparable to 
that of the WT. However, motif 8, with downstream 
motif sequences that included motif 9, exhibited a sig-
nificantly lower ratio than the WT and comparable to 
that when all intron 4 motifs were missing; (iii) motif 8 
formed a sequence-specific shift, and mutation of a cis
-element (CAUC) within motif 8 abrogated the spe-
cific RNA:protein interaction. Although the CAUC 
sequence had been shown previously to be a binding 
site for SRp20 (Ankö et al. 2012, Hargous et al. 2006), 
our present effort did not confirm this; (v) in silico 
analysis and comparison of secondary structure stabil-
ity of intron 4 minigenes with or without motif 8 
showed that secondary structure stability differences 
paralleled the splicing differences observed. Thus, 
both specific sequences and secondary structure stabil-
ity appear to be important for correct splicing. 
 It has been proposed that pre-mRNA secon-
dary structures can influence splicing activity (Buratti 
& Baralle 2004). Numerous studies have shown that 
RNA secondary structure masks or exposes splice 
regulatory elements, or modifies the distance between 
these elements (Hui 2009). For example, mutations in 
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the tau gene intronic region near the 5’ splice site of 
exon 10 correlated closely with alterations in a charac-
teristic stem-loop structure as determined by nuclear 
magnetic resonance spectroscopy (Buratti & Baralle 
2004, Varani et al. 1999). Thus, the predictive ability 
in the search for novel RNA binding targets of proteins 
can be greatly enhanced if the secondary structure is 
taken into consideration. 
 Removal of motif 8 from minigene N had a 
negative effect on the ratio indicating that motif 8 posi-
tively affects splicing in the presence of upstream in-
tron 4 motifs. Because motif 8 by itself also had a 
positive effect, we hypothesized that motif 8 possesses 
important cis-acting splice enhancers. Indeed, motif 8 
was found to contain a unique “CAUC” sequence, a 
potential binding site for SRp20, leading us to further 
hypothesize that SRp20, or an unknown protein, binds 
the conservative sequence of motif 8. A sequence-
specific RNA:protein interaction was consequently 
found between the conserved sequence of motif 8 and 
nuclear protein(s), supporting the hypothesis that the 
decrease in the ratio upon removal of motif 8 directly 
comes from the loss of a binding site for critical regu-
latory protein(s). Moreover, the thermal stability of 
minigene N (that contains motif 8) was similar to the 
WT (albeit slightly higher than WT) as was the ratio of 
completely to incompletely spliced RNA. Together, 
these indicate that the secondary structure, along with 
specific cis elements, may be important for splicing to 
occur properly. 
 However, when motif 8 was used in the pres-
ence of downstream motifs (especially motif 9) the 
ratio decreased, indicating that motif 9 had a dominant 
negative effect on splicing. This observation was fur-
ther confirmed when motif 9 was used by itself, indi-
cating that competing mechanisms (both positive and 
negative) may be at play for normal splicing.  The un-
derlying mechanisms may involve cooperative and/or 
antagonistic effects among regulatory proteins and 
binding for specific cis-elements. The final effect 
would probably rely on the group of factors whose 
function prevails within a given cellular context. Fur-
thermore, comparison of the overall thermal stability 
of minigenes with (minigene G) and without (minigene 
H) motif 8 and downstream motifs, showed that re-
moval of motif 8 resulted in slightly higher stability, 
which was considerably higher than the WT (WT dG: -
220.97 cal/mol; minigene H dG: -238 cal/mol). A 
higher micro-stability of a stem loop structure that may 
contribute to the overall higher stability that was ob-
served in minigene H in the absence of motif 8. We 
speculated that a certain structural fluidity is necessary 
and that a change in the overall stability in either direc-
tion (away from the WT) may have a negative impact 
on splicing. It is also possible that deletion of certain 
motifs affects RNA stability itself. Future experiments 
are warranted to understand the underlying mecha-
nisms of intron 4-mediated processes. 
 The available literature indicates that splicing 
is a complex process. The present findings indicate 
that SP-B splicing is indeed a complex and, most 
likely, a highly coordinated process that relies on the 
combination of several factors, including structural 
stability, and intronic sequence elements for proper 
control.  Mutations that disrupt any of these critical 
features may alter production and/or function of the 
encoded proteins by affecting splicing and/or RNA 
stability. Several naturally occurring deletion and in-
sertion variants have been reported for intron 4, and 
these may result in the retention of part of intron 4 
(Floros et al. 1995, Hamvas et al. 2005, Lin et al. 
2005), as shown in the present study with the mutants 
where intron 4 motifs were systematically removed.  
The incompletely spliced RNA may generate a new 
start or termination codon, or lead to codon frame 
shifts. In this scenario, because the normal mature SP-
B protein is encoded by exons 6 and 7, the total 
amount of normal SP-B protein could decrease. More-
over, even if translation could be activated from an 
AUG within intron 4 in an IRES-dependent way, gen-
eration of abnormal transcripts could not be excluded.   
 In summary, the present findings show that: (i) 
motifs within the SP-B intron 4 can positively or nega-
tively affect SP-B splicing and/or RNA stability; mo-
tifs 8 and 9 in particular may contain ISE and ISS, re-
spectively; (ii) nuclear proteins interact in a sequence-
specific manner with the CAUC element within motif 
8 and this interaction may be important for the positive 
effect of motif 8 on splicing. Future experiments are 
required to identify the binding factors involved in this 
regulation and study how RNA:protein interactions 
can affect SP-B intron RNA splicing and/or stability.  
Another major future step is to develop functional ex-
perimental systems suitable for the interaction of cis 
elements and trans factors within SP-B intron 4. 
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